Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain

The goal of this randomized control clinical trial is to learn if virtual reality can be used to treat sickle cell pain in children. The main questions it aims to answer are: Does virtual reality reduce pain severity during a child's hospital stay for a vaso-occlusive pain crisis? Does virtual reality decrease the daily use of opiates? Researchers will compare standard therapy to the use of standard therapy plus a daily virtual reality experience to see if virtual reality works to treat sickle cell pain. All patients will: \- Be asked to fill out a pain assessment survey three times daily for up to 3 days If randomized to intervention arm, patients will: * Participate in an immersive virtual reality experience once daily for up to 3 days * Fill out a survey twice daily to monitor for side effects from virtual reality experience * Fill out a satisfaction survey once during the study period

NCT Number	NCT06773715
Lead Sponsor	Louisiana State University Health Sciences Center in New Orleans Collaborators: KindVR
Conditions	Sickle Cell Disease, Vaso-occlusive Pain Episodes
Enrollment	36 participants
Start Date	2024-09-12
Primary Completion	2025-12-19 (estimated)
Study Completion	2025-12-19 (estimated)
Updated on ClinicalTrials.gov	2025-01-14